医疗器械行业
- (2022-05-07)
- (2022-05-07)
- (2022-05-07)
- (2022-05-07)
- (2022-05-07)
- (2022-05-07)
- (2022-05-07)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-06)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-05)
- (2022-05-02)
- (2022-05-02)
- (2022-05-02)
- (2022-05-02)
- (2022-05-02)
- (2022-05-02)
- (2022-04-30)
- (2022-04-30)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-29)
- (2022-04-28)
- (2022-04-28)
- (2022-04-28)
JCO:COAST(开放性、II期、多中心研究):单用杜伐单抗或联合奥列单抗或莫那珠单抗治疗不可切除的III期非小细胞肺癌患者的疗效和安全性评估
(2022-04-28)- (2022-04-28)
- (2022-04-28)
- (2022-04-28)
- (2022-04-28)
- (2022-04-28)